Repligen launches AVIPure dsRNA Clear OPUS columns
Repligen (RGEN) announced the launch of AVIPure dsRNA Clear OPUS columns, a solution designed to simplify and enhance the production of mRNA ...
Repligen Launches Novel AVIPure® dsRNA Resin in OPUS® Pre-packed Columns
The AVIPure dsRNA Clear resin launch follows last week’s formal completion by Repligen of its acquisition of Tantti Laboratory Inc., announced on July 29, 2024.